Toray has developed an IC that can detect certain microRNA that occurs with cancer.
Cancer cells produce different kinds of microRNA which are specific to a particular type of cancer, allowing the test to determine which type of cancer has been detected.
The test requires only 50 microlitres of blood and can detect different cancer-types in one go.
Toray is to apply for accelerated permission to sell a cancer screening test requiring one drop of blood and costing $92, reports the Nikkei.
Under Japan’s accelerated approvals procedure, the screening test could be on sale in six months.
Toray says the success rate is 95%.
